Sep 1, 2026 09:07AM
Aug 3, 2026 04:15PM
Jul 8, 2026 06:41AM
Jun 11, 2026 04:23AM
May 4, 2026 04:30PM
Mar 17, 2026 07:12AM
Feb 12, 2026 04:30PM CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Dec 21, 2025 04:00AM
Dec 16, 2025 12:00PM
Dec 9, 2025 11:57AM
Nov 19, 2025 10:06AM
Nov 10, 2025 08:00AM
Oct 31, 2025 09:54AM
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Aug 4, 2025 04:15PM
May 6, 2025 04:01PM
Apr 11, 2025 05:04AM
Apr 4, 2025 01:08PM
Feb 11, 2025 04:01PM
Jan 13, 2025 07:01AM
Jan 13, 2025 07:00AM CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones
Jan 4, 2025 04:00PM
Jan 2, 2025 12:51PM
Dec 9, 2024 12:01PM
Dec 9, 2024 12:00PM
Jan 16, 2024 04:01PM
Jan 16, 2024 04:01PM
Jan 8, 2024 07:07AM CRISPR Therapeutics (CRSP) Highlights Strategic Priorities and 2024 Outlook
Jan 8, 2024 07:00AM
Dec 8, 2023 12:55PM
Dec 8, 2023 12:52PM
Dec 8, 2023 12:09PM
Dec 8, 2023 12:05PM
Dec 8, 2023 11:51AM
Dec 8, 2023 11:20AM FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease (CRSP) (VRTX) (BLUE)
Nov 16, 2023 04:53AM
Nov 16, 2023 01:45AM
Nov 6, 2023 04:15PM
Nov 1, 2023 05:47AM
Oct 31, 2023 05:53PM
Oct 31, 2023 07:10AM
Oct 31, 2023 07:05AM CRISPR Therapeutics Trading Halted Today; FDA Advisory Committee to Review Biologics License Application (BLA) for Exagamglogene Autotemcel (exa-cel) in Sickle Cell Disease (SCD)
Aug 7, 2023 04:01PM
Jun 9, 2023 05:35AM
Jun 9, 2023 05:29AM
Jun 9, 2023 03:01AM
Jun 8, 2023 07:23PM
May 8, 2023 04:01PM
Apr 3, 2023 08:01AM Vertex Pharma (VRTX), CRISPR Therapeutics (CRSP) Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion
Apr 3, 2023 08:00AM

329,912 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All